Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.

Saved in:
Bibliographic Details
Title: Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
Authors: Krishnan, Tharani1 (AUTHOR) tharani.krishnan@bccancer.bc.ca, Safro, Maria1 (AUTHOR), Furlanetto, Daniel Moreira2 (AUTHOR), Gill, Sharlene1 (AUTHOR), Solar Vasconcelos, Joao Paulo1 (AUTHOR), Stuart, Heather C.2 (AUTHOR), Martineau, Patrick1 (AUTHOR), Loree, Jonathan M.1 (AUTHOR)
Source: Journal of Neuroendocrinology. Jan2024, Vol. 36 Issue 1, p1-6. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09538194
DOI:10.1111/jne.13360